187 related articles for article (PubMed ID: 8747492)
1. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.
Laganà A; Pardo-Martínez B; Marino A; Fago G; Bizzarri M
Clin Chim Acta; 1995 Dec; 243(2):165-79. PubMed ID: 8747492
[TBL] [Abstract][Full Text] [Related]
2. Correlation of serum sialic acid fractions as markers for carcinoma of the uterine cervix.
Lagana A; Martinez BP; Marino A; Fago G; Bizzarri M
Anticancer Res; 1995; 15(5B):2341-6. PubMed ID: 8572649
[TBL] [Abstract][Full Text] [Related]
3. The significance of serum lipid-bound sialic acid in bladder tumours.
Oztokatli A; Ozkardeş H; Ovül E; Erol D
Int Urol Nephrol; 1992; 24(2):125-9. PubMed ID: 1624255
[TBL] [Abstract][Full Text] [Related]
4. Significance of serum protein and lipid-bound sialic acid as a marker for genitourinary malignancies.
Erbil KM; Sen SE; Zincke H; Jones JD
Cancer; 1986 Apr; 57(7):1389-94. PubMed ID: 3948121
[TBL] [Abstract][Full Text] [Related]
5. Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix.
Vivas I; Spagnuolo L; Palacios P
Gynecol Oncol; 1992 Aug; 46(2):157-62. PubMed ID: 1500016
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipid bound sialic acid in patients with prostate and bladder cancer.
Dunzendorfer U; Katopodis N; Dnistrian AM; Stock CC; Schwartz MK; Whitmore WF
Invest Urol; 1981 Nov; 19(3):194-6. PubMed ID: 7298291
[TBL] [Abstract][Full Text] [Related]
7. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer.
Tautu C; Pee D; Dunsmore M; Prorok JJ; Alhadeff JA
J Clin Lab Anal; 1991; 5(4):247-54. PubMed ID: 1890538
[TBL] [Abstract][Full Text] [Related]
9. The determination of plasma or serum sialic acid.
Crook M
Clin Biochem; 1993 Feb; 26(1):31-8. PubMed ID: 8448836
[TBL] [Abstract][Full Text] [Related]
10. Serum sialic acid as a marker of pancreatic cancers.
Gruszewska E; Chrostek L; Cylwik B; Tobolczyk J; Szmitkowski M; Kuklinski A; Kedra B
Clin Lab; 2013; 59(7-8):781-8. PubMed ID: 24133906
[TBL] [Abstract][Full Text] [Related]
11. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography-tandem mass spectrometry assay for the quantification of free and total sialic acid in human cerebrospinal fluid.
van der Ham M; de Koning TJ; Lefeber D; Fleer A; Prinsen BH; de Sain-van der Velden MG
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1098-102. PubMed ID: 20362517
[TBL] [Abstract][Full Text] [Related]
13. Serum level of immunosuppressive acidic protein in patients with urological malignancies.
Pu YS; Tsai TC; Chiu TY; Hsieh TS; Chen J; Chen SC; Lin MC; Hsu TC
J Formos Med Assoc; 1991 May; 90(5):498-503. PubMed ID: 1680990
[TBL] [Abstract][Full Text] [Related]
14. Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement.
Plucinsky MC; Riley WM; Prorok JJ; Alhadeff JA
Cancer; 1986 Dec; 58(12):2680-5. PubMed ID: 3779617
[TBL] [Abstract][Full Text] [Related]
15. Quantification of free and total sialic acid excretion by LC-MS/MS.
van der Ham M; Prinsen BH; Huijmans JG; Abeling NG; Dorland B; Berger R; de Koning TJ; de Sain-van der Velden MG
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):251-7. PubMed ID: 17123874
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
Dwivedi C; Dixit M; Hardy RE
Experientia; 1990 Jan; 46(1):91-4. PubMed ID: 2298288
[TBL] [Abstract][Full Text] [Related]
17. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
[TBL] [Abstract][Full Text] [Related]
18. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
Polívková J; Vosmiková K; Pospísil J; Poucková P
Bratisl Lek Listy; 1992 May; 93(5):222-4. PubMed ID: 1393642
[TBL] [Abstract][Full Text] [Related]
19. Assessing benefits of combining biochemical and immunological markers in patients with lung carcinoma.
Patel PS; Raval GN; Rawal RR; Patel GH; Balar DB; Shah PM; Patel DD
Cancer Lett; 1994 Jul; 82(2):129-33. PubMed ID: 8050082
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
López Sáez JJ; Senra-Varela A
Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
